INTENSITY THERAPEUTICS, INC. (INTS)
$3.85+$0.04 (+1.05%) Latest session
Daniel Donovan - Director
Joseph Talamo - OfficerIntensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.
https://www.intensitytherapeutics.comSEC filings for INTS on EDGAR
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 9 | 149,781 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
17 Form 4 filings on record, the earliest from Oct 23, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Thomas I. H. Dubin - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| Daniel Donovan - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| Mark A. Goldberg - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| Emer Leahy - Director | Grant or award | Stock Option (right to buy Common Stock) | 5,500 | $0.00 | - | |
| John M. Wesolowski - Officer | Grant or award | Stock Option (right to buy Common Stock) | 11,000 | $0.00 | - | |
| Joseph Talamo - Officer | Grant or award | Stock Option (right to buy Common Stock) | 34,000 | $0.00 | - | |
| Lewis H. Bender - Officer | Grant or award | Stock Option (right to buy Common Stock) | 78,000 | $0.00 | - | |
| John M. Wesolowski - Officer | Grant or award | Common Stock, $0.0001 Par Value | 3,688 | $3.49 | $13K | |
| Joseph Talamo - Officer | Grant or award | Common Stock, $0.0001 Par Value | 1,093 | $3.49 | $4K | |
| Lewis H. Bender - Officer | Grant or award | Common Stock, $0.0001 Par Value | 37,749 | $6.11 | $231K | |
| Joseph Talamo - Officer | Grant or award | Common Stock, $0.0001 Par Value | 14,179 | $6.53 | $4K | |
| John M. Wesolowski - Officer | Grant or award | Common Stock, $0.0001 Par Value | 69,745 | $6.53 | $18K | |
| Mark A. Goldberg - Director | Grant or award | Stock Option (right to buy Common Stock) | 50,000 | $0.00 | - | |
| Lewis H. Bender - Officer | Grant or award | Stock Option (right to buy Common Stock) | 700,000 | $0.00 | - | |
| Thomas I. H. Dubin - Director | Grant or award | Stock Option (right to buy Common Stock) | 50,000 | $0.00 | - | |
| Joseph Talamo - Officer | Grant or award | Stock Option (right to buy Common Stock) | 427,379 | $0.00 | - | |
| John M. Wesolowski - Officer | Grant or award | Stock Option (right to buy Common Stock) | 70,028 | $0.00 | - |
INTENSITY THERAPEUTICS, INC. (INTS) had 9 insider filings in the last 90 days, with the most recent on 2026-07-20. The full record for INTS runs to 17 Form 4 filings, the earliest from 2024-10-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of INTS were filed in the last 90 days.
No insider sales of INTS were filed in the last 90 days.
This page tracks INTS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add INTS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
